Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Thunstedt

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
MMW Fortschritte Der Medizin|January 17, 2025
[Headache assessment in the GP practice]Cem Thunstedt, Andreas Straube
BMC Medical Education|April 10, 2026
Headache knowledge of young neurologists in GermanyVictoria Ruschil, Cem Thunstedt, Katharina Kamm
BMC Neurology|January 23, 2025
Positive real-time PCR in pneumococcal meningitis 12 hours after initiation of antibiotic therapy - case reportCem Thunstedt, Carla Palleis, Johannes Wischmann, et al.
Brain Sciences|September 28, 2024
Therapeutic Cerebral Fluid Puncture in Patients with Idiopathic Intracranial Hypertension: No Short-Term Effect on Neurocognitive FunctionCem Thunstedt, Dilan Aydemir, Julian Conrad, et al.
Journal of Neurology|February 13, 2022
Reversible cerebral vasoconstriction syndrome after intravenous iron substitution: a case reportKatharina Johanna Müller, Florian Schöberl, Thomas David Fischer, et al.
Frontiers in Oncology|May 23, 2022
The Impact of Postoperative Tumor Burden on Patients With Brain MetastasesAmir Kaywan Aftahy, Melanie Barz, Nicole Lange, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 22, 2024
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real worldEdoardo Caronna, Victor José Gallardo, Gabriella Egeo, et al.
Neurology|January 28, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA CohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Neurology|May 27, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA CohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Cephalalgia : an International Journal of Headache|June 19, 2026
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
MMW Fortschritte Der Medizin|January 17, 2025
[Headache assessment in the GP practice]Cem Thunstedt, Andreas Straube
BMC Medical Education|April 10, 2026
Headache knowledge of young neurologists in GermanyVictoria Ruschil, Cem Thunstedt, Katharina Kamm
BMC Neurology|January 23, 2025
Positive real-time PCR in pneumococcal meningitis 12 hours after initiation of antibiotic therapy - case reportCem Thunstedt, Carla Palleis, Johannes Wischmann, et al.
Brain Sciences|September 28, 2024
Therapeutic Cerebral Fluid Puncture in Patients with Idiopathic Intracranial Hypertension: No Short-Term Effect on Neurocognitive FunctionCem Thunstedt, Dilan Aydemir, Julian Conrad, et al.
Journal of Neurology|February 13, 2022
Reversible cerebral vasoconstriction syndrome after intravenous iron substitution: a case reportKatharina Johanna Müller, Florian Schöberl, Thomas David Fischer, et al.
Frontiers in Oncology|May 23, 2022
The Impact of Postoperative Tumor Burden on Patients With Brain MetastasesAmir Kaywan Aftahy, Melanie Barz, Nicole Lange, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 22, 2024
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real worldEdoardo Caronna, Victor José Gallardo, Gabriella Egeo, et al.
Neurology|January 28, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA CohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Neurology|May 27, 2026
Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA CohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Cephalalgia : an International Journal of Headache|June 19, 2026
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Pageof 1